By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Cronus Technologies and Axela today announced a distribution deal to market Axela's instruments in the UK and Ireland.
Laurence Bouet, Innopsys' managing director, said that the firm has placed about 200 InnoScan scanners so far, mainly in Europe and Asia, but expects to expand its installed base by increasing sales in the US this year.
Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.
Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.
In Science this week: research regulation and reporting requirement reform, and more.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.